First Header Logo Second Header Logo

Walter Ambrosius

Concepts (342)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension
18
2019
913
2.170
Why?
Diabetic Retinopathy
11
2017
64
2.090
Why?
Cardiovascular Diseases
27
2019
1019
1.810
Why?
Mobility Limitation
11
2019
187
1.750
Why?
Blood Pressure
15
2019
807
1.600
Why?
Antihypertensive Agents
11
2019
343
1.570
Why?
Weight Loss
11
2018
414
1.370
Why?
Diabetes Mellitus, Type 2
17
2018
1383
1.340
Why?
Obesity
14
2018
1068
1.260
Why?
Hypoglycemic Agents
9
2017
177
1.170
Why?
Exercise
13
2018
595
1.140
Why?
Aged
62
2019
9516
1.120
Why?
Losartan
3
2019
69
0.920
Why?
Interleukin-6
6
2019
225
0.910
Why?
Humans
89
2019
29249
0.900
Why?
Male
70
2019
17878
0.890
Why?
Female
68
2019
18250
0.870
Why?
Fatty Acids, Omega-3
2
2019
52
0.860
Why?
Life Style
10
2017
364
0.850
Why?
Renal Insufficiency, Chronic
8
2019
271
0.840
Why?
Sample Size
4
2012
37
0.830
Why?
Middle Aged
47
2019
10875
0.790
Why?
Thiazolidinediones
4
2017
47
0.760
Why?
Exercise Therapy
8
2017
229
0.710
Why?
Angiotensin II Type 1 Receptor Blockers
1
2019
68
0.700
Why?
Self Efficacy
4
2017
70
0.680
Why?
Macular Edema
4
2017
14
0.670
Why?
Visual Acuity
4
2017
66
0.650
Why?
Research Design
6
2019
286
0.650
Why?
Data Interpretation, Statistical
2
2010
105
0.640
Why?
Angiotensin-Converting Enzyme Inhibitors
7
2019
134
0.640
Why?
Practice Guidelines as Topic
3
2019
375
0.630
Why?
Walking
8
2017
178
0.570
Why?
Inflammation
7
2019
508
0.560
Why?
Patient Selection
3
2019
257
0.540
Why?
Aged, 80 and over
19
2019
3728
0.520
Why?
Risk Factors
22
2019
3550
0.520
Why?
Kidney Tubules
3
2019
25
0.520
Why?
Motor Activity
5
2015
311
0.510
Why?
Body Mass Index
7
2015
868
0.490
Why?
Patient Care Planning
1
2014
53
0.470
Why?
Informed Consent
1
2013
51
0.460
Why?
Genetic Testing
1
2013
90
0.460
Why?
Body Image
1
2012
13
0.450
Why?
Personal Satisfaction
1
2012
25
0.440
Why?
Self Concept
1
2012
42
0.440
Why?
Uncertainty
1
2012
12
0.420
Why?
Quality of Life
5
2017
820
0.420
Why?
Diagnostic Imaging
1
2012
88
0.400
Why?
Ethnic Groups
1
2013
440
0.390
Why?
Clinical Trials as Topic
2
2018
298
0.390
Why?
Coronary Artery Disease
2
2012
360
0.390
Why?
Risk Reduction Behavior
3
2017
116
0.380
Why?
Blood Glucose
5
2018
467
0.370
Why?
Longitudinal Studies
6
2018
725
0.350
Why?
Aging
5
2017
881
0.340
Why?
Diet, Reducing
5
2013
90
0.340
Why?
Double-Blind Method
5
2019
504
0.330
Why?
Treatment Outcome
12
2018
3109
0.320
Why?
Randomized Controlled Trials as Topic
6
2019
466
0.310
Why?
Psychotherapy, Group
2
2004
15
0.310
Why?
Overweight
3
2013
259
0.300
Why?
Follow-Up Studies
10
2018
2114
0.300
Why?
Counseling
2
2004
86
0.300
Why?
Body Composition
5
2017
365
0.300
Why?
Sacroiliac Joint
1
2007
13
0.290
Why?
Glomerular Filtration Rate
5
2019
287
0.290
Why?
Low Back Pain
1
2007
43
0.290
Why?
Hypertrophy, Left Ventricular
2
2018
110
0.280
Why?
Calcium Channel Blockers
2
2018
49
0.280
Why?
Pilot Projects
4
2019
480
0.280
Why?
Pain Measurement
2
2007
365
0.280
Why?
Blood Pressure Determination
4
2019
94
0.270
Why?
Cognition
3
2017
526
0.270
Why?
Bone and Bones
2
2018
88
0.270
Why?
Age Factors
6
2018
1113
0.260
Why?
Epilepsy
2
2003
59
0.260
Why?
Sex Factors
6
2018
632
0.260
Why?
Sodium
3
2019
37
0.250
Why?
Severity of Illness Index
6
2018
864
0.250
Why?
Incidence
7
2018
1123
0.250
Why?
Diabetic Angiopathies
3
2014
137
0.240
Why?
Gene Frequency
1
2004
225
0.240
Why?
Proportional Hazards Models
4
2018
710
0.230
Why?
Geriatric Assessment
3
2017
356
0.230
Why?
Anti-Dyskinesia Agents
1
2003
5
0.230
Why?
Muscle Spasticity
1
2003
24
0.220
Why?
Attention Deficit Disorder with Hyperactivity
1
2003
28
0.220
Why?
Biometry
1
2002
12
0.220
Why?
Botulinum Toxins
1
2003
37
0.220
Why?
Education, Medical, Continuing
1
2002
45
0.220
Why?
Time Factors
7
2018
2005
0.210
Why?
Catheters, Indwelling
1
2002
40
0.210
Why?
Fractures, Bone
2
2015
150
0.210
Why?
Stroke
2
2017
549
0.210
Why?
Adult
17
2017
8470
0.210
Why?
Catheterization, Central Venous
1
2002
60
0.200
Why?
Adrenergic beta-Antagonists
3
2014
59
0.200
Why?
Cross-Sectional Studies
6
2019
1367
0.200
Why?
Single-Blind Method
6
2018
165
0.200
Why?
Genetic Predisposition to Disease
2
2004
837
0.200
Why?
Disability Evaluation
3
2018
211
0.190
Why?
Physicians
1
2002
135
0.190
Why?
Simvastatin
2
2018
25
0.190
Why?
Bayes Theorem
3
2017
69
0.190
Why?
Software
2
2015
110
0.180
Why?
Renal Dialysis
1
2002
261
0.180
Why?
Resistance Training
2
2017
70
0.180
Why?
Disease Management
2
2018
114
0.170
Why?
European Continental Ancestry Group
3
2013
1131
0.170
Why?
National Institutes of Health (U.S.)
1
2019
29
0.170
Why?
Health Education
3
2016
121
0.170
Why?
United States
7
2019
3648
0.170
Why?
Parathyroid Hormone
1
2018
40
0.170
Why?
Hyperglycemia
3
2014
82
0.170
Why?
Fibroblast Growth Factors
1
2018
34
0.160
Why?
Diuretics
1
2018
22
0.160
Why?
Systole
2
2018
88
0.160
Why?
Albuminuria
1
2019
177
0.160
Why?
Actigraphy
1
2017
12
0.160
Why?
Hand Strength
2
2015
85
0.160
Why?
Mental Disorders
1
2019
111
0.160
Why?
Diagnostic Techniques, Ophthalmological
2
2014
8
0.150
Why?
Prognosis
6
2019
1365
0.150
Why?
Thrombolytic Therapy
1
2017
59
0.150
Why?
Cause of Death
2
2015
220
0.150
Why?
Ischemic Attack, Transient
1
2017
46
0.150
Why?
Sex Distribution
2
2011
186
0.150
Why?
Health Status
3
2015
369
0.140
Why?
Brain Ischemia
1
2017
136
0.140
Why?
Dyslipidemias
2
2013
52
0.140
Why?
Goals
1
2015
36
0.130
Why?
Managed Care Programs
2
2005
38
0.130
Why?
Analysis of Variance
3
2013
454
0.130
Why?
Motor Skills Disorders
1
2014
4
0.130
Why?
Multivariate Analysis
2
2013
638
0.120
Why?
Sodium Chloride Symporter Inhibitors
1
2014
10
0.120
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2014
10
0.120
Why?
Medicaid
2
2005
83
0.120
Why?
Decision Trees
1
2014
23
0.120
Why?
Quality Assurance, Health Care
2
2005
62
0.120
Why?
Independent Living
1
2015
79
0.120
Why?
Sodium Channels
2
2005
13
0.120
Why?
Osteoarthritis, Knee
2
2005
80
0.120
Why?
Tomography, X-Ray Computed
3
2018
871
0.120
Why?
ROC Curve
1
2014
149
0.120
Why?
Clinical Protocols
1
2014
95
0.120
Why?
Prospective Studies
3
2011
2028
0.120
Why?
Disease Progression
4
2019
572
0.120
Why?
Insulin
1
2015
346
0.120
Why?
Asian Americans
1
2013
98
0.120
Why?
Medicare
2
2005
187
0.110
Why?
Educational Status
1
2013
165
0.110
Why?
Photography
1
2013
33
0.110
Why?
Radius
1
2013
21
0.110
Why?
Bone Density
4
2018
183
0.110
Why?
African Continental Ancestry Group
2
2005
350
0.110
Why?
Tibia
1
2013
56
0.110
Why?
African Americans
2
2013
1373
0.110
Why?
Diabetic Nephropathies
1
2014
195
0.110
Why?
Sensitivity and Specificity
3
2018
533
0.100
Why?
Cognition Disorders
1
2014
390
0.100
Why?
Models, Statistical
1
2012
164
0.100
Why?
Retrospective Studies
4
2017
3123
0.100
Why?
Cohort Studies
4
2018
1695
0.090
Why?
Age Distribution
1
2011
198
0.090
Why?
Observation
1
2010
24
0.090
Why?
Smoking
1
2013
439
0.090
Why?
Risk Assessment
2
2018
1313
0.090
Why?
Public Health
1
2011
73
0.090
Why?
Calcium
1
2012
297
0.090
Why?
Ligands
1
2010
81
0.090
Why?
Feeding Behavior
1
2011
159
0.090
Why?
Cholesterol, LDL
2
2010
157
0.090
Why?
Chi-Square Distribution
1
2010
293
0.090
Why?
Diabetes Mellitus
1
2013
370
0.090
Why?
Heart Failure
2
2005
573
0.090
Why?
Cystic Fibrosis
1
2009
23
0.080
Why?
Odds Ratio
1
2010
448
0.080
Why?
Magnetic Resonance Imaging
1
2014
1221
0.080
Why?
Oxygen Consumption
1
2009
138
0.080
Why?
Predictive Value of Tests
2
2017
788
0.080
Why?
North Carolina
5
2013
1425
0.080
Why?
Neuropsychological Tests
2
2014
379
0.080
Why?
Energy Metabolism
1
2009
139
0.080
Why?
Insurance, Pharmaceutical Services
1
2007
5
0.080
Why?
Drug Therapy
1
2007
16
0.080
Why?
Health Benefit Plans, Employee
1
2007
14
0.080
Why?
Hispanic Americans
1
2013
904
0.080
Why?
Injections, Intra-Articular
1
2007
12
0.070
Why?
Physical Fitness
2
2009
120
0.070
Why?
Health Expenditures
1
2007
61
0.070
Why?
Sickness Impact Profile
1
2007
35
0.070
Why?
Amiloride
2
2005
5
0.070
Why?
Gait
1
2007
115
0.070
Why?
Statistics as Topic
1
2007
107
0.070
Why?
Survival Rate
2
2019
795
0.070
Why?
Prevalence
2
2015
907
0.070
Why?
Risk
2
2019
290
0.070
Why?
Anesthetics, Local
1
2007
77
0.070
Why?
Sampling Studies
2
2003
40
0.070
Why?
Adolescent
5
2009
3267
0.070
Why?
Case-Control Studies
2
2009
862
0.070
Why?
Oxalates
1
2005
2
0.070
Why?
Drug Utilization Review
1
2005
17
0.070
Why?
Sodium Channel Blockers
1
2005
7
0.070
Why?
C-Reactive Protein
4
2011
232
0.070
Why?
Child
4
2009
2225
0.070
Why?
Movement
1
2005
41
0.070
Why?
Hypercholesterolemia
1
2006
59
0.070
Why?
Kidney Calculi
1
2005
25
0.070
Why?
Kidney Tubules, Proximal
1
2005
39
0.070
Why?
Dose-Response Relationship, Drug
2
2018
641
0.070
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2005
1
0.070
Why?
Monte Carlo Method
1
2004
18
0.060
Why?
Muscle Strength
2
2017
139
0.060
Why?
Calibration
1
2004
25
0.060
Why?
Markov Chains
1
2004
25
0.060
Why?
Hypoglycemia
2
2015
41
0.060
Why?
Enalapril
1
2004
7
0.060
Why?
Depression
1
2007
383
0.060
Why?
Statistical Distributions
1
2004
5
0.060
Why?
Drug Therapy, Combination
2
2018
273
0.060
Why?
Genes, Dominant
1
2004
26
0.060
Why?
Physical Conditioning, Animal
1
2004
32
0.060
Why?
Quantitative Trait, Heritable
1
2004
47
0.060
Why?
Comorbidity
2
2003
546
0.060
Why?
Genetic Markers
1
2004
122
0.060
Why?
Models, Genetic
1
2004
94
0.060
Why?
Antibiotics, Antitubercular
1
2003
1
0.060
Why?
Oxidoreductases, N-Demethylating
1
2003
5
0.060
Why?
Aryl Hydrocarbon Hydroxylases
1
2003
6
0.060
Why?
Rifampin
1
2003
7
0.060
Why?
Creatinine
2
2019
174
0.060
Why?
Alleles
1
2004
251
0.060
Why?
Intestines
1
2003
54
0.060
Why?
Indiana
1
2003
4
0.060
Why?
Internet
1
2004
158
0.060
Why?
Potassium
1
2002
37
0.060
Why?
Electroencephalography
1
2003
71
0.050
Why?
Diabetes Complications
2
2015
171
0.050
Why?
Genetic Variation
1
2004
251
0.050
Why?
Faculty
1
2002
15
0.050
Why?
Child Behavior Disorders
1
2002
11
0.050
Why?
Genotype
1
2004
735
0.050
Why?
Brain Injuries
1
2003
94
0.050
Why?
Antineoplastic Agents
1
2007
547
0.050
Why?
Exercise Tolerance
2
2015
110
0.050
Why?
Adiposity
2
2013
192
0.050
Why?
Muscle, Skeletal
1
2005
494
0.050
Why?
Curriculum
1
2002
196
0.050
Why?
Neoplasms
1
2007
612
0.050
Why?
Liver
1
2003
464
0.050
Why?
Diet
2
2017
356
0.050
Why?
Psychotherapy
1
2019
17
0.040
Why?
Fibrosis
1
2019
103
0.040
Why?
Up-Regulation
1
2019
183
0.040
Why?
Feasibility Studies
1
2019
267
0.040
Why?
Absorptiometry, Photon
1
2018
129
0.040
Why?
Blood Pressure Monitoring, Ambulatory
1
2018
26
0.040
Why?
Homeostasis
1
2018
127
0.040
Why?
Confidence Intervals
1
2018
141
0.040
Why?
Eicosapentaenoic Acid
1
2017
26
0.040
Why?
Glucose
1
2018
164
0.040
Why?
Secondary Prevention
1
2017
59
0.040
Why?
Young Adult
2
2017
2413
0.040
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
126
0.040
Why?
Survival Analysis
1
2018
440
0.040
Why?
Patient Discharge
1
2017
169
0.030
Why?
Combined Modality Therapy
1
2017
525
0.030
Why?
Caregivers
1
2017
94
0.030
Why?
Patient Satisfaction
1
2017
223
0.030
Why?
Survivors
1
2017
145
0.030
Why?
Patient Education as Topic
1
2017
252
0.030
Why?
Kidney
1
2019
486
0.030
Why?
Psychometrics
1
2015
129
0.030
Why?
Cataract Extraction
1
2014
8
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2017
327
0.030
Why?
Guideline Adherence
2
2005
111
0.030
Why?
Activities of Daily Living
2
2005
240
0.030
Why?
Disabled Persons
1
2014
83
0.030
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
14
0.030
Why?
Fundus Oculi
1
2013
11
0.030
Why?
Interleukin-8
1
2013
23
0.030
Why?
Movement Disorders
1
2013
25
0.030
Why?
Community Health Centers
1
2013
13
0.030
Why?
Muscle Development
1
2013
45
0.030
Why?
Observer Variation
1
2013
96
0.030
Why?
Leptin
1
2013
66
0.030
Why?
Behavior Therapy
1
2013
92
0.030
Why?
Adiponectin
1
2013
103
0.030
Why?
Electrocardiography
1
2017
568
0.030
Why?
Chronic Disease
2
2004
370
0.030
Why?
Linear Models
1
2013
427
0.030
Why?
Accidental Falls
1
2012
207
0.020
Why?
Respiratory Function Tests
1
2009
111
0.020
Why?
Formularies as Topic
1
2007
3
0.020
Why?
Tablets
1
2007
10
0.020
Why?
Prescription Fees
1
2007
6
0.020
Why?
Cost Sharing
1
2007
10
0.020
Why?
Drugs, Generic
1
2007
13
0.020
Why?
Cost Control
1
2007
17
0.020
Why?
Drug Utilization
1
2007
47
0.020
Why?
Brain
1
2014
930
0.020
Why?
Program Evaluation
1
2007
175
0.020
Why?
Exercise Test
1
2007
194
0.020
Why?
Medical Audit
1
2005
14
0.020
Why?
Knee
1
2005
31
0.020
Why?
Spironolactone
1
2005
11
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2005
46
0.020
Why?
Cross-Over Studies
1
2005
95
0.020
Why?
Kidney Function Tests
1
2005
102
0.020
Why?
Reference Values
1
2005
224
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2004
45
0.020
Why?
Rats, Inbred BN
1
2004
32
0.020
Why?
Total Quality Management
1
2004
19
0.020
Why?
Rats, Inbred F344
1
2004
125
0.020
Why?
Medical Records
1
2004
68
0.010
Why?
Biotransformation
1
2003
5
0.010
Why?
Cytochrome P-450 CYP3A
1
2003
4
0.010
Why?
Oxidative Stress
1
2005
223
0.010
Why?
Biological Availability
1
2003
21
0.010
Why?
Midazolam
1
2003
11
0.010
Why?
Random Allocation
1
2004
213
0.010
Why?
Injections, Intravenous
1
2003
73
0.010
Why?
Hypnotics and Sedatives
1
2003
27
0.010
Why?
Area Under Curve
1
2003
85
0.010
Why?
Tumor Necrosis Factor-alpha
1
2004
200
0.010
Why?
Chromatography, High Pressure Liquid
1
2003
93
0.010
Why?
Mass Spectrometry
1
2003
100
0.010
Why?
Administration, Oral
1
2003
169
0.010
Why?
Pain
1
2005
282
0.010
Why?
Aldosterone
1
2002
28
0.010
Why?
Posture
1
2002
53
0.010
Why?
Cytokines
1
2004
243
0.010
Why?
Sex Characteristics
1
2003
167
0.010
Why?
Child Behavior
1
2002
26
0.010
Why?
Renin
1
2002
112
0.010
Why?
Health Promotion
1
2003
220
0.010
Why?
Algorithms
1
2003
463
0.010
Why?
Rats
1
2004
1606
0.010
Why?
Animals
1
2004
7315
0.010
Why?
Ambrosius's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (342)
Explore
_
Co-Authors (38)
Explore
_
Similar People (53)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_